Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.
about
Estrogen regulation of cyclin E2 requires cyclin D1 but not c-MycTReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesteroneTherapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1Deciphering the divergent roles of progestogens in breast cancer.Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiationDistinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.Divergent behavior of cyclin E and its low molecular weight isoforms to progesterone-induced growth inhibition in MCF-7 cells.Regulation of CDK4Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).Mifepristone inhibits ovarian cancer cell growth in vitro and in vivoImproving cytocompatibility of Co28Cr6Mo by TiO2 coating: gene expression study in human endothelial cellsMolecular mechanisms underlying progesterone-enhanced breast cancer cell migration.Integrated actions of progesterone receptor and cell cycle machinery regulate breast cancer cell proliferation.A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.Down-regulation of ribosomal protein S15A inhibits proliferation of human glioblastoma cells in vivo and in vitro via AKT pathway.Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation.Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene.Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells.Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.Regulation of p21 and p27 expression by the hepatitis B virus X protein and the alternate initiation site X proteins, AUG2 and AUG3.Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesterone.
P2860
Q24653031-8E48A90A-2D23-49B2-AE6C-D206B99FF978Q24671974-3D6934AE-69CF-44E5-B09B-A5D79AD64463Q27851564-72C280F4-2AF2-46D8-9C39-5F70EE75CA3FQ28206102-9FD4390A-E898-4C14-A4FF-4A8167618FCFQ30240711-F246BB3D-6B04-4B56-956E-0AFAA06E7DBFQ30578094-798E7565-CEE0-4D2B-AA1A-A54119018C66Q33428469-EE609718-7706-488B-B3F7-C6BB8C70FF25Q33734599-67F13061-1B1C-45C6-A240-6E5E54EB20C2Q33931217-B8FB28F2-52CE-4441-962C-54984CBDCF61Q34190232-C1FCFD30-A5E1-4259-A44C-5D0E7B23C6A4Q34990893-6A4B8B57-F32B-439D-9F37-82ACDD558C31Q35147982-F7FA095B-F7D7-4E78-A39E-7FBF5FA9A5D5Q35604651-BA68823E-13D2-410B-90DB-39FE594DD379Q36826054-1E93A29D-9D13-4945-9296-6DDB0B1F6EB5Q37062716-336EB9F2-9F16-46A0-A56B-B6C7863545ACQ37166756-ACC2CB72-D102-4169-AFFD-064EC27E2263Q37360938-9B2BE432-C367-408F-AE05-6964EBC39E40Q38308285-D1EE62E2-4364-49F5-9F9B-1800A41AD38AQ38821975-37824DFB-927A-4B03-A23C-556CCC20A008Q40114088-161D782C-A7FF-48A5-BAEA-D829D629BF10Q40363540-2FADFDA8-AF8D-40BB-983F-9F33D34E4DECQ40398127-FE2B1EC0-21F8-46C4-859B-4B16A5AE4279Q40503186-5253FFC9-C55D-486A-BEF9-DDFBEA6CC8EFQ43759022-FE5836F6-CCEC-4471-9ECF-648C4631F85EQ44373694-99BA3F2C-BDE0-430C-84D2-0259C85EB1DFQ44669637-8600F2EE-6EE6-4667-A620-5CE2D44FB479
P2860
Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cooperation of p27(Kip1) and p ...... in T-47D breast cancer cells.
@ast
Cooperation of p27(Kip1) and p ...... in T-47D breast cancer cells.
@en
type
label
Cooperation of p27(Kip1) and p ...... in T-47D breast cancer cells.
@ast
Cooperation of p27(Kip1) and p ...... in T-47D breast cancer cells.
@en
prefLabel
Cooperation of p27(Kip1) and p ...... in T-47D breast cancer cells.
@ast
Cooperation of p27(Kip1) and p ...... in T-47D breast cancer cells.
@en
P2093
P2860
P1476
Cooperation of p27(Kip1) and p ...... t in T-47D breast cancer cells
@en
P2093
E A Musgrove
R L Sutherland
P2860
P304
P356
10.1128/MCB.20.7.2581-2591.2000
P407
P577
2000-04-01T00:00:00Z